Reimbursed with a limitationOriginator productATC N04BC09

Neupro

Neupro is an originator product from UCB-Pharma SA and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 28.00 to CHF 149.10 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
UCB-Pharma SA
ATC code
N04BC09
IT group
01.08 Parkinson
Active substances
Rotigotinum
Preparation type
Originator product
On the SL since
01/12/2006
Last price change
01/12/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Neupro Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Matrixpfl 1 mg/24hBtl 7 StkCHF 10.65CHF 28.0001/05/2018B7680574170236
Matrixpfl 1 mg/24hBtl 28 StkCHF 34.94CHF 54.4001/05/2018B7680574170298
Matrixpfl 2 mg/24hBtl 7 StkCHF 16.60CHF 34.4501/05/2018B7680574170304
Matrixpfl 2 mg/24hBtl 28 StkCHF 54.44CHF 75.6001/05/2018B7680574170311
Matrixpfl 3 mg/24hBtl 7 StkCHF 16.66CHF 34.5501/05/2018B7680574170328
Matrixpfl 3 mg/24hBtl 28 StkCHF 54.62CHF 75.8001/05/2018B7680574170335
Matrixpfl 4 mg/24hBtl 7 StkCHF 27.22CHF 46.0001/05/2018B7680574170342
Matrixpfl 4 mg/24hBtl 28 StkCHF 89.27CHF 113.5001/05/2018B7680574170359
Matrixpfl 6 mg/24hBtl 7 StkCHF 30.29CHF 49.3501/05/2018B7680574170366
Matrixpfl 6 mg/24hBtl 28 StkCHF 99.33CHF 124.4501/05/2018B7680574170373
Matrixpfl 8 mg/24hBtl 28 StkCHF 121.99CHF 149.1001/05/2018B7680574170380

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/05/2018

Zur Behandlung von Patienten mit mittelschwerem - schwerem idiopathischem Restless-Legs-Syndrom, wenn die vorgängige Therapie mit oralen Dopamin-Agonisten unzulänglich war. Die Erstverschreibung muss durch einen Neurologen erfolgen.

FOPH wordingValid from 01/05/2018

Zur Behandlung von Patienten mit mittelschwerem - schwerem idiopathischem Restless-Legs-Syndrom, wenn die vorgängige Therapie mit oralen Dopamin-Agonisten unzulänglich war. Die Erstverschreibung muss durch einen Neurologen erfolgen.
Zur Behandlung der idiopathischen Parkinson-Erkrankung.

FOPH wordingValid from 01/05/2018

Zur Behandlung der idiopathischen Parkinson-Erkrankung.

FAQ

Is Neupro covered by Swiss health insurance?

Yes, but only under conditions. Neupro is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Neupro cost in Switzerland?

The public price is the maximum price set by the FOPH and for Neupro ranges from CHF 28.00 to CHF 149.10 per pack. The ex-factory price ranges from CHF 10.65 to CHF 121.99. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com